UnitedHealth Group Incorporated $UNH Stock Position Increased by Woodmont Investment Counsel LLC

Woodmont Investment Counsel LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,368 shares of the healthcare conglomerate’s stock after buying an additional 1,760 shares during the period. Woodmont Investment Counsel LLC’s holdings in UnitedHealth Group were worth $6,354,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Patriot Financial Group Insurance Agency LLC raised its position in shares of UnitedHealth Group by 6.0% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 3,729 shares of the healthcare conglomerate’s stock worth $1,953,000 after purchasing an additional 211 shares during the period. RDA Financial Network raised its position in shares of UnitedHealth Group by 3.4% during the first quarter. RDA Financial Network now owns 9,282 shares of the healthcare conglomerate’s stock worth $4,861,000 after purchasing an additional 304 shares during the period. Finally, ARS Wealth Advisors Group LLC raised its position in shares of UnitedHealth Group by 3.6% during the first quarter. ARS Wealth Advisors Group LLC now owns 28,650 shares of the healthcare conglomerate’s stock worth $15,005,000 after purchasing an additional 1,004 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8%

UnitedHealth Group stock opened at $360.17 on Monday. The business has a 50 day moving average price of $307.84 and a two-hundred day moving average price of $353.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% on a year-over-year basis. During the same period last year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Wells Fargo & Company decreased their price target on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Finally, Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.